Genedrive PLC (LON:GDR)

Genedrive PLC (LON:GDR)


Share Price
21.56 p
Change
0.56 (2.67 %)
Market Cap
£4.05 m
Proactive Investors - Run By Investors For Investors

Genedrive PLC

Genedrive® is our rapid and low cost molecular diagnostics platform for the identification and treatment selection of infectious diseases, human genotyping, animal health, pathogen identification, and other applicationsent and improving prognosis.

EPIC: GDR
Market: AIM:GDR
52-week High/Low: 42.00p / 18.00p
Sector: Pharma & Biotech
Market Cap: 4.05M
Website: www.genedrive.com
col 3
col 4
col 5
col 6

Big picture - Why invest in Genedrive PLC


Genedrive PLC Timeline

Genedrive's PLC (LON: GDR) HepC test just entered the commercial phase as partner Sysmex launched in EMEA and APAC territories  in recent weeks Re-design of the mTB test in progress, launch date to be announced in the next fiscal year Discussions for the disposal of the Services business entered an...
CN Video

Riccardo Lowi discusses Genedrive Plc

Riccardo Lowi, analyst at Capital Network on the launch preparation of Genedrive® HCV test with partner Sysmex on track, expect sales to start coming through in CY2018.
Overall Genedrive PLC (LON: GDR) reported a business and financial update for the six months to December 2017 in line with expectations Launch preparation of Genedrive® HCV test with partner Sysmex on track, expect sales to start coming through in CY2018 £1.3mln income from the ongoing collaboration with...

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use